These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors. Tavernier E; Le QH; Elhamri M; Thomas X Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972 [TBL] [Abstract][Full Text] [Related]
4. The management of acute myelogenous leukemia in the elderly: ten-year experience in 118 patients. Bassan R; Buelli M; Viero P; Minotti C; Barbui T Hematol Oncol; 1992; 10(5):251-60. PubMed ID: 1493909 [TBL] [Abstract][Full Text] [Related]
5. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of bone marrow and peripheral blood cytologic features in hyperleukocytic acute leukemia]. Liu YL; Liu HB; Wang WJ; Ma L; Wang XN; Liu HS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):562-6. PubMed ID: 23815898 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report. Vogler WR; Raney MR Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256 [TBL] [Abstract][Full Text] [Related]
8. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML). Dick FR; Burns CP; Weiner GJ; Heckman KD Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259 [TBL] [Abstract][Full Text] [Related]
9. Morphometric study of megakaryocytes size and prognosis in adults with acute non-lymphocytic leukemia. Brody JP; Krause JR Leuk Res; 1986; 10(5):475-80. PubMed ID: 3713247 [TBL] [Abstract][Full Text] [Related]
10. Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease. Ollila TA; Olszewski AJ; Butera JN; Quesenberry MI; Quesenberry PJ; Reagan JL Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):204-209. PubMed ID: 29433979 [TBL] [Abstract][Full Text] [Related]
12. [New data about oligoblastic leukemias. Apropos of an analysis of 120 cases]. Izrael V; Jacquillat C; Chastang C; Weil M; de Heaulme M; Boiron M; Bernard J Nouv Presse Med; 1975 Mar; 4(13):947-52. PubMed ID: 1144035 [TBL] [Abstract][Full Text] [Related]
13. Short-term remission induction and consolidation therapy for adult acute myelogenous leukemia. Battista R; Bassan R; D'Emilio A; Dragone P; Viero P; Dini E; Barbui T Hematol Oncol; 1991; 9(1):43-52. PubMed ID: 2045069 [TBL] [Abstract][Full Text] [Related]
14. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity. Riccardi A; Giordano M; Girino M; Cazzola M; Montecucco CM; Cassano E; Danova M; Ucci G; Castello A; Coci A Blut; 1987 Mar; 54(3):153-63. PubMed ID: 3814832 [TBL] [Abstract][Full Text] [Related]
15. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study. Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343 [TBL] [Abstract][Full Text] [Related]
16. Treatment-related leukemia in Hodgkin's disease: a multi-institution study on 75 cases. Brusamolino E; Papa G; Valagussa P; Mandelli F; Bernasconi C; Marmont A; Bonadonna G; Tura S; Bosi A; Mango G Hematol Oncol; 1987; 5(2):83-98. PubMed ID: 2439431 [TBL] [Abstract][Full Text] [Related]
17. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors. Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome. Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690 [TBL] [Abstract][Full Text] [Related]
19. Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity. de Bock R; de Jonge M; Korthout M; Wouters E; van Bockstaele D; van der Planken M; Peetermans M Ann Hematol; 1992 Dec; 65(6):247-52. PubMed ID: 1457585 [TBL] [Abstract][Full Text] [Related]
20. Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. Wiley JS; Jones SP; Sawyer WH; Paterson AR J Clin Invest; 1982 Feb; 69(2):479-89. PubMed ID: 6948829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]